Moreover, dysregulation of WNT/β-catenin signaling and cell cycle regulation [via the p53/retinoblastoma-associated protein (RB1) axis] are significant hallmarks of ACC and the pathways most frequently affected by driver mutations (Assié et al., 2014; Zheng et al., 2016). This evidence concerns the gene TP53 and adrenal cortex carcinoma.